Patents by Inventor Daniel M. Bernstein

Daniel M. Bernstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230346269
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: June 23, 2023
    Publication date: November 2, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Patent number: 11737687
    Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: August 29, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Mark K. Sloan, Martin J. Fennell, Daniel M. Bernstein
  • Publication number: 20230233112
    Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    Type: Application
    Filed: April 4, 2023
    Publication date: July 27, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark K. SLOAN, Martin J. FENNELL, Daniel M. BERNSTEIN
  • Publication number: 20230143496
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: January 10, 2023
    Publication date: May 11, 2023
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Patent number: 11586273
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: February 21, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Patent number: 11571147
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: February 7, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Publication number: 20220391009
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various checks and combinations of checks including installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 8, 2022
    Inventors: Daniel M. BERNSTEIN, Saeed Nekoomaram, Mark K. Sloan
  • Publication number: 20220369926
    Abstract: Systems, methods, and devices for improved sensor communications in an analyte monitoring system are provided. In some embodiments, a first remote device can be configured establish a first wireless communication link with a sensor control device. The first remote device can then transmit sensor context information to a second remote device and deactivate the first wireless communication link. Subsequently, the second remote device can establish a second wireless communication link with the sensor control device by using the sensor context information.
    Type: Application
    Filed: October 28, 2020
    Publication date: November 24, 2022
    Inventors: Daniel M. Bernstein, Jim Asnis, Nikhil Desai, Amrit Preet Bains, Sujit Jangam, Jordan Wing-Haye Lang
  • Publication number: 20220280122
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: May 11, 2022
    Publication date: September 8, 2022
    Inventors: Timothy C. DUNN, Kenneth J. DONIGER, Glenn BERMAN, Gary A. HAYTER, Erwin S. BUDIMAN, Daniel M. BERNSTEIN, Nathan CROUTHER
  • Publication number: 20220221927
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various checks and combinations of checks including installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Application
    Filed: March 30, 2022
    Publication date: July 14, 2022
    Inventors: Daniel M. BERNSTEIN, Saeed Nekoomaram, Mark K. Sloan
  • Patent number: 11331051
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: May 17, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Patent number: 11327554
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: May 10, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Patent number: 11301027
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various checks and combinations of checks including installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: April 12, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Publication number: 20220011851
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various checks and combinations of checks including installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Application
    Filed: September 28, 2021
    Publication date: January 13, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Publication number: 20210365102
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Patent number: 11099627
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: August 24, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Publication number: 20210225524
    Abstract: Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes.
    Type: Application
    Filed: April 9, 2021
    Publication date: July 22, 2021
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis
  • Patent number: 11033211
    Abstract: On-body units are provided and include a transcutaneous analyte sensor, electronic circuitry electrically coupled to the sensor, and an on-body housing having electrical contacts disposed thereon. The on-body housing comprises a substantially flat surface and a curved and convex surface opposite the substantially flat surface. Systems and methods including the on-body units are also provided. Methods for performing continuity measurements using on-body units are also provided. The methods include positioning an on-body unit (OBU) on a skin of a subject, contacting a continuity test instrument to the OBU; and performing a continuity measurement with the continuity test instrument. An AC signal may be provided across two electrical contacts, or a DC signal may be provided across two electrical contacts in opposite directions for the same amount of time. The measurement may be performed with one electrical contact, or with isolated electrical contacts.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: June 15, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Daniel M. Bernstein
  • Patent number: 11017890
    Abstract: An analyte measurement system includes one or more handheld analyte meters and/or measurement devices and a means for collecting data, preserving data integrity, and uniquely identifying patient data received from multiple sources. For example, provided herein is a means to uniquely identify patients and their data when the data is collected from one or more measurement devices. By providing a way to allow the patients to use multiple sources to collect data, the system described herein provides patients with more flexibility, which should encourage better compliance to protocols. Further, by having a way to uniquely identify patients' data without requiring a patient to only use one analyte meter, for example, data can be centralized and analysis can be done with more assurance that all of the patient's data is being considered in the analyses.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: May 25, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Daniel M. Bernstein, Gary A. Hayter, Timothy C. Dunn, Mani Gopal, Eric Davis, Brittany K. Bradrick, Todd Winkler
  • Patent number: D994695
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: August 8, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis